Home / Pharma Healthcare / Global Total Artificial Heart (TAH) Sales Market Report 2016

Global Total Artificial Heart (TAH) Sales Market Report 2016

  • Id : RNR-15829
  • Category : Pharma Healthcare
  • Publish Date : 6-Oct
  • Pages : 128
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Total Artificial Heart (TAH)
Revenue, means the sales value of Total Artificial Heart (TAH)

This report studies sales (consumption) of Total Artificial Heart (TAH) in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
    Baxter International, Inc. (USA)
    Abbott Diabetes Care, Inc. (USA)
    Vital Therapies, Inc. (USA)
    Xenios AG (Germany)
    Asahi Kasei Medical Co., Ltd. (Japan)
    Medtronic, Inc. (USA)
    HeartWare International, Inc. (USA)
    Fresenius Medical Care AG & Co. KGaA (Germany)
    Jarvik Heart, Inc. (USA)
    Toray Medical Co., Ltd. (Japan)
    Nikkiso Co., Ltd. (Japan)
    Nipro Corporation (Japan)
    SynCardia Systems, Inc. (USA)
    Terumo Heart, Inc. (USA)
    Thoratec Corp. (USA)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Total Artificial Heart (TAH) in these regions, from 2011 to 2021 (forecast), like
    USA
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of Total Artificial Heart (TAH) in each application, can be divided into
    Application 1
    Application 2
    Application 3